troglitazone has been researched along with Asthma, Bronchial in 1 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhu, M | 1 |
| Flynt, L | 1 |
| Ghosh, S | 1 |
| Mellema, M | 1 |
| Banerjee, A | 1 |
| Williams, E | 1 |
| Panettieri, RA | 1 |
| Shore, SA | 1 |
1 other study available for troglitazone and Asthma, Bronchial
| Article | Year |
|---|---|
Anti-inflammatory effects of thiazolidinediones in human airway smooth muscle cells.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Anilides; Anti-Inflammatory Agents; Antim | 2011 |